Literature DB >> 22864830

p38α MAP kinase phosphorylates RCAN1 and regulates its interaction with calcineurin.

Lei Ma1, Haiping Tang, Yan Ren, Haiteng Deng, Jiawei Wu, Zhixin Wang.   

Abstract

RCAN1, also known as DSCR1, is an endogenous regulator of calcineurin, a serine/threonine protein phosphatase that plays a critical role in many physiological processes. In this report, we demonstrate that p38α MAP kinase can phosphorylate RCAN1 at multiple sites in vitro and show that phospho-RCAN1 is a good protein substrate for calcineurin. In addition, we found that unphosphorylated RCAN1 noncompetitively inhibits calcineurin protein phosphatase activity and that the phosphorylation of RCAN1 by p38α MAP kinase decreases the binding affinity of RCAN1 for calcineurin. These findings reveal the molecular mechanism by which p38α MAP kinase regulates the function of RCAN1/calcineurin through phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22864830     DOI: 10.1007/s11427-012-4340-9

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  6 in total

Review 1.  Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.

Authors:  Yili Wu; Philip T T Ly; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

2.  Quercetin targets the interaction of calcineurin with LxVP-type motifs in immunosuppression.

Authors:  Yane Zhao; Jin Zhang; Xiaoyu Shi; Jing Li; Rui Wang; Ruiwen Song; Qun Wei; Huaibin Cai; Jing Luo
Journal:  Biochimie       Date:  2016-04-22       Impact factor: 4.079

Review 3.  Meeting at the crossroads: common mechanisms in Fragile X and Down syndrome.

Authors:  Karen T Chang; Hyunah Ro; Wei Wang; Kyung-Tai Min
Journal:  Trends Neurosci       Date:  2013-09-25       Impact factor: 13.837

Review 4.  Calcineurin in the heart: New horizons for an old friend.

Authors:  Malay Chaklader; Beverly A Rothermel
Journal:  Cell Signal       Date:  2021-08-25       Impact factor: 4.315

Review 5.  RCAN1-mediated calcineurin inhibition as a target for cancer therapy.

Authors:  Mengyi Lao; Xiaozhen Zhang; Hanshen Yang; Xueli Bai; Tingbo Liang
Journal:  Mol Med       Date:  2022-06-18       Impact factor: 6.376

6.  The structure of the RCAN1:CN complex explains the inhibition of and substrate recruitment by calcineurin.

Authors:  Yang Li; Sarah R Sheftic; Simina Grigoriu; Charles D Schwieters; Rebecca Page; Wolfgang Peti
Journal:  Sci Adv       Date:  2020-07-01       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.